402959-34-6 Usage
Uses
Used in Pharmaceutical Industry:
[(S)-1-(CYCLOPROPYLCARBAMOYL-HYDROXY-METHYL)-BUTYL]-CARBAMIC ACID BENZYL ESTER is used as a key intermediate in the synthesis of peptides for the treatment of hepatitis C virus. Its unique structure allows for the development of therapeutic agents that can target and combat the virus effectively.
In the preparation of peptides, [(S)-1-(CYCLOPROPYLCARBAMOYL-HYDROXY-METHYL)-BUTYL]-CARBAMIC ACID BENZYL ESTER serves as a building block or a modifying agent, enabling the creation of novel peptide-based drugs with enhanced antiviral properties. Its incorporation into peptide structures can improve the pharmacokinetic and pharmacodynamic profiles of the resulting therapeutics, making them more effective in treating hepatitis C virus infections.
Check Digit Verification of cas no
The CAS Registry Mumber 402959-34-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,2,9,5 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 402959-34:
(8*4)+(7*0)+(6*2)+(5*9)+(4*5)+(3*9)+(2*3)+(1*4)=146
146 % 10 = 6
So 402959-34-6 is a valid CAS Registry Number.
402959-34-6Relevant academic research and scientific papers
SYNTHESIS OF AN INTERMEDIATE OF AN ANTIVIRAL COMPOUND
-
, (2013/09/26)
Process for the preparation of a cyclopropylamide compound which is useful as a structural unit in a process for the preparation of a viral protease inhibitor.
Processes and intermediates
-
Page/Page column 40-41, (2010/11/26)
The invention relates to compounds and processes useful for the preparation of protease inhibitors, particularly serine protease inhibitors. The protease inhibitors are useful for treatment of HCV infections.
